Insmed Inc (INSM)
70.59
+0.15
(+0.21%)
USD |
NASDAQ |
Dec 23, 16:00
70.58
-0.01
(-0.01%)
After-Hours: 20:00
Insmed Profit Margin (Quarterly): -236.0% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | -22.27% |
| Cytokinetics Inc | -34.67K% |
| Amicus Therapeutics Inc | -4.75% |
| Collegium Pharmaceutical Inc | 5.86% |
| Krystal Biotech Inc | 32.42% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -56.29% |
| Return on Invested Capital | -85.94% |
| Gross Profit Margin (Quarterly) | 77.34% |
| Operating Margin (Quarterly) | -212.7% |
| Return on Net Operating Assets | -200.4% |